Halozyme Therapeutics, Inc.

UNITED CAPITAL FINANCIAL ADVISORS, LLC HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

16,059

Value ($000)

1,081

Weight

0.0%

2013 Q4 - 2025 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	1,081	0.0%	16,059	12/31/2025
2025 Q3	11/14/2025	1,057	0.0%	14,414	9/30/2025
2025 Q1	5/13/2025	221	0.0%	3,460	3/31/2025
2024 Q2	8/14/2024	202	0.0%	3,858	6/30/2024
2023 Q3	11/14/2023	287	0.0%	7,516	9/30/2023
2023 Q2	8/14/2023	276	0.0%	7,639	6/30/2023
2023 Q1	8/15/2023	299	0.0%	7,826	3/31/2023
2022 Q4	2/15/2023	516	0.0%	9,060	12/31/2022
2022 Q3	11/14/2022	356	0.0%	8,995	9/30/2022
2022 Q2	8/11/2022	769	0.0%	17,468	6/30/2022
2022 Q1	5/16/2022	360	0.0%	9,015	3/31/2022
2021 Q4	2/14/2022	360	0.0%	8,965	12/31/2021
2021 Q3	11/15/2021	364	0.0%	8,960	9/30/2021
2021 Q2	8/13/2021	407	0.0%	8,965	6/30/2021
2021 Q1	5/14/2021	374	0.0%	8,965	3/31/2021
2020 Q4	2/17/2021	383	0.0%	8,965	12/31/2020
2020 Q3	11/13/2020	235	0.0%	8,960	9/30/2020
2020 Q2	8/13/2020	240	0.0%	8,960	6/30/2020
2014 Q1	5/14/2014	133	0.0%	10,500	3/31/2014
2013 Q4	2/20/2014	210	0.0%	14,002	12/31/2013